MS-Selfie

MS-Selfie

Home
Notes
MS-Selfie Research
MS-Selfie Microsite
Contact
Q&A
Archive
Leaderboard
About
Research News #2: EBV and MS
None of these studies is definitive in its own right; they are simply pieces of a large black jigsaw puzzle (black box) that is currently filling one…
 • Gavin Giovannoni
Q&A 145: MS and Obsessive Compulsive Disorder or OCD
Comorbid OCD is commoner than you realise in people with MS. Do you want to know more about it?
 • Gavin Giovannoni
22:37
Understanding your liver function tests or LFTs
How healthy is your liver? Do you know how to interpret your LFT blood results?
 • Gavin Giovannoni
Q&A 144: drug-induced liver injury
Correction, I was wrong. Transaminitis defined as a rise in ALT greater than 3x or greater than 10x the upper limit of normal, is actually lower with…
 • Gavin Giovannoni
Q&A 143 - ACTRIMS 2026: BTK inhibition in PPMS
“MS at a Crossroads” - a new treatment for Primary Progressive Multiple Sclerosis
 • Gavin Giovannoni
Research News #1
I am launching a new MS-Selfie feature called “Research News” in which I will review research papers that have caught my attention over the last week or…
 • Gavin Giovannoni
What is an MS label?
These MS labels have now become sticky and inform clinical practice. What label best describes your MS?
 • Gavin Giovannoni
Q&A 142: Epsilon toxin and MS
One hypothesis I have spent less time discussing is the so-called ‘dual-hit’ hypothesis, i.e. EBV sets the stage for another factor such as a toxin to…
 • Gavin Giovannoni

January 2026

© 2026 Gavin Giovannoni · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture